Early treatment with a sodium-glucose co-transporter 2 inhibitor in high-risk patients with acute heart failure: Rationale for and design of the EMPA-AHF trial.
暂无分享,去创建一个
D. Nitta | A. Voors | T. Kitai | Shuntaro Sato | K. Damman | T. Okumura | Kazuki Yoshida | T. Shibata | M. Hoshino | Y. Matsue | Yu Horiuchi | K. Nogi | Ken Onitsuka | K. Yoshida | Tatsuhiro Shibata